Vascular biology of metabolic syndrome

Journal of Vascular Surgery

Volumn 54, Issue 3, 2011, Pages 819-831

  Vykoukal, Daynene ^a   Davies, Mark G ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANGIOTENSINOGEN; APELIN; C REACTIVE PROTEIN; CHEMERIN; FATTY ACID; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN PROTEIN; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; RETINOL BINDING PROTEIN 4; SECRETORY PROTEIN; SERUM AMYLOID A; SOMATOMEDIN; STAT3 PROTEIN; THROMBOPLASTIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASPIN; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD CLOTTING; BODY MASS; BROWN ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CATABOLISM; CELL HYPOXIA; CELL INFILTRATION; CHRONIC INFLAMMATION; CORTICOSTEROID METABOLISM; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISORDERS OF LIPOPROTEIN METABOLISM; HISTOGENESIS; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOXIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNCYTIUM; THROMBOCYTE ACTIVATION; THROMBOSIS; TISSUE INJURY; VASCULAR BIOLOGY; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BLOOD COAGULATION; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; SIGNAL TRANSDUCTION;

EID: 79960853510     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.01.003     Document Type: Article

References (169)

1. R. Kahn Metabolic syndromewhat is the clinical usefulness? Lancet 371 2008 1892 1893
2. J. Belch Medical management of intermittent claudication R.M. Greenhalgh, Vascular and endovascular opportunities 2000 W B Saunders London 361 388
3. F.G. Fowkes, E. Housley, R.A. Riemersma, C.C. Macintyre, E.H. Cawood, and R.J. Prescott Smoking, lipids, glucose intolerance and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Arterial Study Am J Epidemiol 135 1992 331 340
4. O. Brandman, and W. Redisch Incidence of peripheral vascular changes in diabetes mellitus: a survey of 264 cases Diabetes 2 1953 194 198
5. L. Ramsey, B. Williams, G. Johnston, G. MacGregor, L. Poston, and J. Porter Guidelines for management of the British Hypertension Society: report of the working party of the British Hypertension Society J Hum Hypertens 13 1999 569 592 (Pubitemid 29438528)
6. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
7. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553 (Pubitemid 28319935)
8. J.B. Meigs, P.W.F. Wilson, D.M. Nathan, R.B. D'Agostino Sr, K. Williams, and S.M. Haffner Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and the Framingham offspring studies Diabetes 52 2003 2160 2167 (Pubitemid 36919812)
9. Y.-W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, and S.B. Heyisfield The metabolic syndome: prevalence and associated risk factor findings in the US popluation from the third national health and nutritional examination survey Arch Intern Med 163 2003 427 436 (Pubitemid 36241019)
10. P. Banne-Parikka, J.G. Eriksson, J. Linstrom, H. Hamalainen, S. Keinanen-Kiukanniemi, and M. Laakso Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the diabetes prevention study cohort Diabetes Care 27 2004 2135 2140 (Pubitemid 39167175)
11. R.H. Eckel, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome Lancet 365 2005 1415 1428 (Pubitemid 40523737)
12. P.M. Gorter, J.K. Olijhoek, Y. van der Graaf, A. Algra, T.J. Rabelink, and F.L. Visseren Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm Atherosclerosis 173 2004 363 369 (Pubitemid 38469808)
13. G. Brevetti, V. Schiano, G. Sirico, G. Giugliano, E. Laurenzano, and M. Chiariello Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity J Vasc Surg 44 2006 101 107 (Pubitemid 43975268)
14. C.H. Saely, K. Geiger, and H. Drexel Brown versus white adipose tissue: a mini-review Gerontology 2010 Dec 7 [Epublication ahead of print]
15. N. Halberg, I. Wernstedt-Asterholm, and P.E. Scherer The adipocyte as an endocrine cell Endocrinol Metab Clin North Am 37 2008 753 768
16. S.M. Haffner Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 120 2007 S10 S17
17. J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, and S.M. Hofmann Obesity-associated improvements in metabolic profile through expansion of adipose tissue J Clin Invest 117 2007 2621 2637 (Pubitemid 47494363)
18. C.H. Cho, Y.J. Koh, J. Han, H.K. Sung, H. Jong-Lee, and T. Morisada Angiogenic role of LYVE-1-positive macrophages in adipose tissue Circ Res 100 2007 e47 e57
19. N. Halberg, T. Khan, M.E. Trujillo, I. Wernstedt-Asterholm, A.D. Attie, and S. Sherwani HIF 1alpha induces fibrosis and insulin resistance in white adipose tissue Mol Cell Biol 117 2000 4467 4483
20. S. Landskroner-Eiger, B. Qian, E.S. Muise, A.R. Nawrocki, J. Berger, and E.J. Fine Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo Clin Cancer Res 15 2009 3265 3276
21. K.E. Wellen, and G.S. Hotamisligil Obesity-induced inflammatory changes in adipose tissue J Clin Invest 112 2003 1785 1788 (Pubitemid 38063699)
22. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808 (Pubitemid 38063703)
23. G.B. Di Gregorio, A. Yao-Borengasser, N. Rasouli, V. Varma, T. Lu, and L.M. Miles Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone Diabetes 54 2005 2305 2313 (Pubitemid 41134256)
24. S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, and E. Faloia Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J Lipid Res 46 2005 2347 2355 (Pubitemid 41532523)
25. K.J. Strissel, Z. Stancheva, H. Miyoshi, J.W. Perfield, J. DeFuria, and Z. Jick Adipocyte death, adipose tissue remodeling, and obesity complications Diabetes 56 2007 2910 2918 (Pubitemid 350223625)
26. J.V. Silha, M. Krsek, P. Sucharda, and L.J. Murphy Angiogenic factors are elevated in overweight and obese individuals Int J Obes (Lond) 29 2005 1308 1314 (Pubitemid 41679261)
27. N. Nils-Halberg, I. Wernstedt, and P.E. Scherer The adipocyte as an endocrine cell Endocrinol Metab Clin North Am 37 2008 753 xi
28. P. Trayhurn, and W.I.S. Adipokines Inflammation and the pleiotropic role of white adipose tissue Br J Nutr 92 2004 347 355 (Pubitemid 40277057)
29. P. Trayhurn, B. Wang, and I.S. Wood Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100 2008 227 235
30. N. Hosogai, A. Fukuhara, K. Oshima, Y. Miyata, S. Tanaka, and K. Segawa Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation Diabetes 56 2007 901 911 (Pubitemid 46525054)
31. B. Wang, I.S. Wood, and P. Trayhurn Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes Pflgers Arch 455 2007 479 492 (Pubitemid 47624196)
32. S. Virtue, and A. Vidal-Puig Adipose tissue expandability, lipotoxicity and the metabolic syndromean allostatic perspective Biochim Biophys Acta 180 2010 338 349
33. R. Meshkani, and K. Adeli Hepatic insulin resistance, metabolic syndrome and cardiovascular disease Clin Biochem 42 2009 1331 1346
34. I. Palomo, M. Alarcón, R. Moore-Carrasco, and J.M. Argilés Hemostasis alterations in metabolic syndrome Int J Mol Med 18 2006 969 974
35. X. Prieur, T. Roszer, and M. Ricote Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome Biochim Biophys Acta 180 2010 327 337
36. F. Assimacopoulos-Jeannet Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type 2 diabetes Int J Obes Relat Metab Disord 28 suppl e 2004 S53 S57
37. G. Boden, and G.I. Shulman Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction Eur J Clin Invest 32 suppl e 2002 14 23 (Pubitemid 41704996)
38. R. Belfort, L. Mandarino, S. Kashyap, K. Wirfel, T. Pratipanawatr, and R. Berria Doseresponse effect of elevated plasma free fatty acid on insulin signaling Diabetes 54 2005 1640 1648 (Pubitemid 40770753)
39. G. Zea Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes Mol Endocrinol 18 2004 2024 2034
40. T. Hajri, X.X. Han, A. Bonen, and N.A. Abumrad Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice J Clin Invest 109 2002 1381 1389 (Pubitemid 34546903)
41. J.M. Ye, P.J. Doyle, M.A. Iglesias, D.G. Watson, G.J. Cooney, and E.W. Kraegen Peroxisome proliferator-activated receptor (PPAR)-a activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation Diabetes 50 2001 411 417 (Pubitemid 32127300)
42. K. Karastergioua, and V. Mohamed-Alia The autocrine and paracrine roles of adipokines Mol Cell Endocrin 318 2010 69 78
43. M. Matsuda, and I. Shimomura Adipocytokines and metabolic syndromemolecular mechanism and clinical implication Nippon Rinsho 62 2004 1085 1090
44. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770 (Pubitemid 28485436)
45. I.S. Farooqi, T. Wangensteen, S. Collins, W. Kimber, G. Matarese, and J.M. Keogh Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor N Engl J Med 356 2007 237 247 (Pubitemid 46143227)
46. C.T. Montague, I.S. Farooqi, J.P. Whitehead, M.A. Soos, H. Rau, and N.J. Wareham Congenital leptin deficiency is associated with severe early-onset obesity in humans Nature 387 1997 903 908 (Pubitemid 27289591)
47. C. Buettner, A. Pocai, E.D. Muse, A.M. Etgen, M.G. Myers Jr, and L. Rossetti Critical role of STAT3 in leptin's metabolic actions Cell Metab 4 2006 49 60 (Pubitemid 43942253)
48. C. Buettner, E.D. Muse, A. Cheng, L. Chen, T. Scherer, and A. Pocai Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms Nat Med 14 2008 667 675 (Pubitemid 351809549)
49. G.M. Lord, G. Matarese, J.K. Howard, R.J. Baker, S.R. Bloom, and R.I. Lechler Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression Nature 394 1998 897 901 (Pubitemid 28410912)
50. S. Loffreda, S.Q. Yang, H.Z. Lin, C.L. Karp, M.L. Brengman, and D.J. Wang Leptin regulates proinflammatory immune responses FASEB J 12 1998 57 65 (Pubitemid 28060271)
51. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
52. A. Banga, A.M. Bodles, N. Rasouli, G. Ranganathan, P.A. Kern, and R.J. Owens Calcium is involved in formation of high molecular weight adiponectin Metab Syndr Relat Disord 6 2008 103 111 (Pubitemid 351769258)
53. U.B. Pajvani, X. Du, T.P. Combs, A.H. Berg, M.W. Rajala, and T. Schulthess Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin Implications for metabolic regulation and bioactivity J Biol Chem 278 2003 9073 9085 (Pubitemid 36800387)
54. Y. Wang, K.S. Lam, L. Chan, K.W. Chan, J.B. Lam, and M.C. Lam Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex J Biol Chem 281 2006 16391 16400
55. Y. Wang, K.S. Lam, M.H. Yau, and A. Xu Post-translational modifications of adiponectin: mechanisms and functional implications Biochem J 409 2008 623 633 (Pubitemid 351214189)
56. C.M. Kusminski, P.G. McTernan, T. Schraw, K. Kos, J.P. O'Hare, and R. Ahima Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum Diabetologia 50 2007 634 642 (Pubitemid 46215508)
57. N. Kubota, W. Yano, T. Kubota, T. Yamauchi, S. Itoh, and H. Kumagai Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake Cell Metab 6 2007 55 68 (Pubitemid 47007437)
58. P.A. Kern, G.B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 52 2003 1779 1785 (Pubitemid 36792470)
59. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, and R.E. Pratley Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935 (Pubitemid 32472900)
60. C. Heidemann, Q. Sun, R.M. van Dam, J.B. Meigs, C. Zhang, and S.S. Tworoger Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women Ann Intern Med 149 2008 307 316
61. C. Lara-Castro, N. Luo, P. Wallace, R.L. Klein, and W.T. Garvey Adiponectin multimeric complexes and the metabolic syndrome trait cluster Diabetes Metab Res Rev 55 2006 249 259 (Pubitemid 43343322)
62. Z.V. Wang, T.D. Schraw, J.Y. Kim, T. Khan, M.W. Rajala, and A. Follenzi Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention Mol Cell Biol 27 2007 3716 3731 (Pubitemid 46726179)
63. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 2006 1784 1792 (Pubitemid 44033298)
64. J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, and S.M. Hofmann Obesity-associated improvements in metabolic profile through expansion of adipose tissue J Clin Invest 117 2007 2621 2637 (Pubitemid 47494363)
65. N. Rasouli, A. Yao-Borengasser, L.M. Miles, S.C. Elbein, and P.A. Kern Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression Am J Physiol Endocrinol Metab 290 2006 E42 E46
66. A.M. Bodles, A. Banga, N. Rasouli, F. Ono, P.A. Kern, and R.J. Owens Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes Am J Physiol Endocrinol Metab 291 2006 E1100 E1105
67. U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doebber, and J.P. Berger Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity J Biol Chem 274 2004 12152 12162 (Pubitemid 38445780)
68. N. Rasouli, U. Raue, L.M. Miles, T. Lu, G.B. Di Gregorio, and S.C. Elbein Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue Am J Physiol Endocrinol Metab 288 2005 E930 E934
69. A.R. Nawrocki, M.W. Rajala, E. Tomas, U.B. Pajvani, A.K. Saha, and M.E. Trumbauer Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists J Biol Chem 281 2006 2654 2660 (Pubitemid 43845727)
70. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr Rev 26 2005 439 451 (Pubitemid 40686653)
71. W. Zhu, K.K.Y. Cheng, P.M. Vanhoutte, K.S.L. Lam, and A. Xu Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention Clin Sci Lond 114 2008 361 374 (Pubitemid 351397385)
72. C.M. Steppan, E.J. Brown, C.M. Wright, S. Bhat, R.R. Banerjee, and C.Y. Dai A family of tissue-specific resistin-like molecules Proc Natl Acad Sci U S A 98 2001 502 506 (Pubitemid 32105071)
73. C.A. Curat, V. Wegner, C. Sengenes, A. Miranville, C. Tonus, and R. Busse Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin Diabetologia 49 2006 744 747 (Pubitemid 43357549)
74. S.D. Patel, M.W. Rajala, L. Rossetti, P.E. Scherer, and L. Shapiro Disulfidedependent Multimeric assembly of resistin family hormones Science 304 2004 1154 1158 (Pubitemid 38661851)
75. M. Degawa-Yamauchi, J.E. Bovenkerk, B.E. Juliar, W. Watson, K. Kerr, and R. Jones Serum resistin (FIZZ3) protein is increased in obese humans J Clin Endocrinol Metab 88 2003 5452 5455 (Pubitemid 37452753)
76. L.K. Heilbronn, J. Rood, L. Janderova, J.B. Albu, D.E. Kelley, and E. Ravussin Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects J Clin Endocrinol Metab 89 2004 1844 1848 (Pubitemid 38507943)
77. J.H. Lee, J.L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, and R. Seip Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects J Clin Endocrinol Metab 88 2003 4848 4856 (Pubitemid 37357535)
78. B. Vozarova-deCourten, M. Degawa-Yamauchi, R.V. Considine, and P.A. Tataranni High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians Diabetes 53 2004 1279 1284 (Pubitemid 38569014)
79. M.F. Hivert, L.M. Sullivan, C.S. Fox, D.M. Nathan, R.B. D'Agostino Sr, and P.W. Wilson Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance J Clin Endocrinol Metab 93 2008 3165 3172
80. D. Kamin, C. Hadigan, M. Lehrke, S. Mazza, M.A. Lazar, and S. Grinspoon Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone J Clin Endocrinol Metab 90 2005 3423 3426 (Pubitemid 41014307)
81. S. Gavi, S. Qurashi, L.M. Stuart, R. Lau, M.M. Melendez, and D.C. Mynarcik Influence of age on the association of retinol-binding protein 4 with metabolic syndrome Obesity (Silver Spring) 16 2008 893 895 (Pubitemid 351465649)
82. A. Yao-Borengasser, V. Varma, A.M. Bodles, N. Rasouli, B. Phanavanh, and M.J. Lee Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone J Clin Endocrinol Metab 92 2007 2590 2597 (Pubitemid 47037362)
83. N. Mody, T.E. Graham, Y. Tsuji, Q. Yang, and B.B. Kahn Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice Am J Physiol Endocrinol Metab 294 2008 E85 E93
84. T. Kitani, S. Okuno, and H. Fujisawa Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor FEBS Lett 544 2003 74 78 (Pubitemid 36628039)
85. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol Cell Biol 14 1994 1431 1437
86. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, and K. Kishimoto Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 (Pubitemid 40139988)
87. J. Berndt, N. Kloting, S. Kralisch, P. Kovacs, M. Fasshauer, and M.R. Schon Plasma visfatin concentrations and fat depot-specific mRNA expression in humans Diabetes 54 2005 2911 2916 (Pubitemid 41401086)
88. V. Varma, A. Yao-Borengasser, N. Rasouli, A.M. Bodles, B. Phanavanh, and M.J. Lee Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipid, and inflammation J Clin Endocrinol Metab 92 2007 666 672
89. T.B. Dahl, A. Yndestad, M. Skjelland, E. Oie, A. Michelsen, and J.K. Damas Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization Circulation 115 2007 972 980 (Pubitemid 46328290)
90. S. Kralisch, J. Klein, U. Lossner, M. Bluher, R. Paschke, and M. Stumvoll Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes FEBS Lett 579 2005 6417 6422 (Pubitemid 41612161)
91. S. Kralisch, U. Lossner, M. Bluher, R. Paschke, M. Stumvoll, and M. Fasshauer Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by beta-adrenergic stimulation in 3T3-L1 adipocytes J Endocrinol 189 2006 665 670
92. E. Dusserre, P. Moulin, and H. Vidal Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues Biochim Biophys Acta 1500 2000 88 96 (Pubitemid 29525402)
93. V. Van Harmelen, P. Ariapart, J. Hoffstedt, I. Lundkvist, S. Bringman, and P. Arner Increased adipose angiotensinogen gene expression in human obesity Obes Res 8 2000 337 341
94. F. Massiera, M. Bloch-Faure, and D. Cellier Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation FASEB J 5 2001 2727 2729
95. C.M. de Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, and J. Pray Omentin plasma levels and gene expression are decreased in obesity Diabetes 56 2007 1655 1661 (Pubitemid 46842600)
96. A. Schaffler, M. Neumeier, H. Herfarth, A. Furst, J. Scholmerich, and C. Buchler Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue Biochim Biophys Acta 1732 2005 96 102 (Pubitemid 43267310)
97. R.Z. Yang, M.J. Lee, H. Hu, J. Pray, H.B. Wu, and B.C. Hansen Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am J Physiol Endocrinol Metab 290 2006 E1253 E1261
98. K. Bozaoglu, K. Bolton, J. McMillan, P. Zimmet, J. Jowett, and G. Collier Chemerin is a novel adipokine associated with obesity and metabolic syndrome Endocrinology 148 2007 4687 4694 (Pubitemid 47481514)
99. K.B. Goralski, T.C. McCarthy, E.A. Hanniman, B.A. Zabel, E.C. Butcher, and S.D. Parlee Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism J Biol Chem 282 2007 28175 28188 (Pubitemid 47529521)
100. D.K. Lee, S.R. George, and B. O'Dowd Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity Trends Pharmacol Sci 27 2006 190 194
101. K. Hida, J. Wada, J. Eguchi, H. Zhang, M. Baba, and A. Seida Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity Proc Natl Acad Sci U S A 102 2005 10610 10615 (Pubitemid 41061602)
102. N. Kloting, J. Berndt, S. Kralisch, P. Kovacs, M. Fasshauer, and M.R. Schon Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes Biochem Biophys Res Commun 339 2006 430 436 (Pubitemid 41697566)
103. C.A. Curat, V. Wegner, C. Sengenes, A. Miranville, C. Tonus, and R. Russe Macropages in human visceral adipose tissue: increased accumulation in obesity and source of resistin and visfatin Diabetologia 49 2006 744 747 (Pubitemid 43357549)
104. E. Leinonen, E. Hurt-Camejo, O. Wiklund, L.M. Hulten, A. Hiukka, and M.R. Taskinen Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes Atherosclerosis 166 2003 387 394 (Pubitemid 36071698)
105. Y. Lin, M.W. Rajala, J.P. Berger, D.E. Moller, N. Barzilai, and P.E. Scherer Hyperglycemia-induced production of acute phase reactants in adipose tissue J Biol Chem 276 2001 42077 42083
106. C. Poitou, A. Viguerie, R. Cancello, R. De Matteis, S. Cinti, and V. Stich Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition Diabetologia 48 2005 519 528 (Pubitemid 40487299)
107. R.S. Schwartz, S. Osborne-Lawrence, L. Hahner, L.L. Gibson, A.K. Gormley, and W. Vongpatanasin C-reactive protein downregulates endothelial no synthase and attenuates reendothelialization in vivo in mice Circ Res 100 2007 1452 1459 (Pubitemid 46834757)
108. J.W. Xu, I. Morita, K. Ikeda, T. Miki, and Y. Yamori C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase protein Mol Endocrinol 21 2006 564 573
109. S.E. Crawford, V. Stellmach, J.E. Murphy-Ullrich, S.M. Ribeiro, J. Lawler, and R.O. Hynes Thrombospondin-1 is a major activator of TGF-β1 in vivo Cell Metab 93 1998 1159 1170 (Pubitemid 28307421)
110. M. Febbraio, D.P. Hajjar, and R.L. Silverstein CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism J Clin Invest 108 2001 785 791 (Pubitemid 32880285)
111. P. Bornstein Thrombospondins as matricellular modulators of cell function J Clin Invest 107 2001 929 934 (Pubitemid 32323400)
112. V. Varma, A. Yao-Borengasser, A.M. Bodles, N. Rasouli, B. Phanavanh, and G.T. Nolen Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance Diabetes 57 2008 432 439
113. A. Lteif, P. Vaishnava, A.D. Baron, and K.J. Mather Endothelin limits insulin action in obese/insulin-resistant humans Diabetes 56 2007 728 734 (Pubitemid 46348477)
114. G. Ahlborg, A. Shemyakin, F. Bohm, A. Gonon, and J. Pernow Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease Diabetes Care 30 2007 591 596 (Pubitemid 46354339)
115. M. Brownlee, A. Cerami, and H. Vlassara Advanced products of non-enzymatic glycosylation and the pathogenesis of diabetic vascular disease Diabetes/Metabol Rev 4 1988 437 451
116. G.S. Getz Report on the workshop on diabetes and mechanisms of atherogenesis September 17th and 18th, 1992, Bethesda, Maryland Arterioscler Thromb 13 1993 459 464 (Pubitemid 23075636)
117. D.K. Agrawal, S. Bhimji, and J.H. McNeill Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery J Cardiovasc Pharmacol 9 1987 584 593 (Pubitemid 17069876)
118. K.M. MacLeod, and J.H. McNeill The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels Can J Physiol Pharmacol 63 1985 52 57 (Pubitemid 15148317)
119. T. Koschinsky, C.E. Bunting, R. Rutter, and F.A.S. Gries Vascular growth factors and the development of macrovascular disease in diabetes mellitus Diabetes Metabol 13 1987 318 325 (Pubitemid 17105092)
120. V. Fuster Progression-regression of atherosclerosis: molecular, cellular and clinical bases Circulation 86 suppl III 1992 1 123
121. M.A. Potenza, F. Addabbo, and M. Montagnani Vascular actions of insulin with implications for endothelial dysfunction Am J Physiol Endocrinol Metab 297 2009 E568 E577
122. K.T. Uysal, S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 1997 610 614 (Pubitemid 27446179)
123. K.T. Uysal, S.M. Wiesbrock, and G.S. Hotamisligil Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity Endocrinology 139 1998 4832 4838 (Pubitemid 28533428)
124. P.A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 280 2001 E745 E751
125. P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J.R. Zierath, and B.K. Pedersen Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 54 2005 2939 2945 (Pubitemid 41401090)
126. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
127. F. Ofei, S. Hurel, J. Newkirk, M. Sopwith, and R. Taylor Effects of an engineered human Anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM Diabetes 45 1996 881 885 (Pubitemid 26225502)
128. M.A. Gonzalez-Gay, J.M. De Matias, C. Gonzalez-Juanatey, C. Garcia-Porrua, A. Sanchez-Andrade, and J. Martin Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis Clin Exp Rheumatol 24 2006 83 86
129. B. Seriolo, C. Ferrone, and M. Cutolo Longterm anti-tumor necrosis factor-alpha treatment in patients with refractory rheumatoid arthritis: relationship between insulin resistance and disease activity J Rheumatol 35 2008 355 357 (Pubitemid 351281162)
130. L.S. Tam, B. Tomlinson, T.T. Chu, T.K. Li, and E.K. Li Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis Clin Rheumatol 26 2007 1495 1498 (Pubitemid 47201685)
131. M.D. Sury, M. Frese-Schaper, M.K. Muhlemann, F.T. Schulthess, I.E. Blasig, and M.G. Tauber Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase Free Radic Biol Med 41 2006 1372 1383 (Pubitemid 44466721)
132. C. Rask-Madsen, H. Dominguez, N. Ihlemann, T. Hermann, L. Kober, and C. Torp-Pedersen Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans Circulation 108 2003 1815 1821 (Pubitemid 37296090)
133. B. Emanuelli, P. Peraldi, C. Filloux, D. Sawka-Verhelle, D. Hilton, and E. Van Obberghen SOCS-3 is an insulin-induced negative regulator of insulin signaling J Biol Chem 275 2000 15985 15991 (Pubitemid 30366903)
134. O.P. Kristiansen, and T. Mandrup-Poulsen Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54 suppl 2 2005 S114 S124
135. N.B. Ruderman, C. Keller, A.M. Richard, A.K. Saha, Z. Luo, and X. Xiang Interleukin-6 regulation of AMP-activated protein kinase Potential role in the systemic response to exercise and prevention of the metabolic syndrome Diabetes 55 suppl 2 2006 S48 S54
136. G.B. Di Gregorio, L. Hensley, T. Lu, G. Ranganathan, and P.A. Kern Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity Am J Physiol Endocrinol Metab 287 2004 E182 E187
137. V. Wallenius, K. Wallenius, B. Ahren, M. Rudling, H. Carlsten, and S.L. Dickson Interleukin-6-deficient mice develop mature-onset obesity Nat Med 8 2002 75 79 (Pubitemid 34101732)
138. F. Andreozzi, E. Laratta, C. Procopio, M.L. Hribal, A. Sciacqua, and M. Perticone Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells Mol Cell Biol 27 2007 2372 2383 (Pubitemid 46418488)
139. J. Spranger, A. Kroke, M. Mohlig, K. Hoffmann, M.M. Bergmann, and M. Ristow Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 52 2003 812 817 (Pubitemid 36323590)
140. E. van Exel, J. Gussekloo, A.J. Craen, M. Frolich, A. Bootsma-VanDer Wiel, and R.G. Westendorp Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study Diabetes 51 2002 1088 1092 (Pubitemid 34438354)
141. M. Straczkowski, I. Kowalska, A. Nikolajuk, A. Krukowska, and M. Gorska Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals Diabetes Care 28 2005 2036 2037 (Pubitemid 41060983)
142. K. Esposito, A. Pontillo, C. Di Palo, G. Giugliano, M. Masella, and R. Marfella Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial JAMA 289 2003 1799 1804 (Pubitemid 37430249)
143. H.J. Kim, T. Higashimori, S.Y. Park, H. Choi, J. Dong, and Y.J. Kim Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo Diabetes 53 2004 1060 1067 (Pubitemid 38436619)
144. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J Clin Invest 117 2007 175 184 (Pubitemid 46048464)
145. P. Sartipy, and D.J. Loskutoff Monocyte chemoattractant protein 1 in obesity and insulin resistance Proc Natl Acad Sci U S A 100 2003 7265 7270 (Pubitemid 36706427)
146. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808 (Pubitemid 38063703)
147. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, and R. Kitazawa MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J Clin Invest 116 2006 1494 1505
148. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, and C.J. Chou Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830 (Pubitemid 38063705)
149. F.W. Kiefer, M. Zeyda, J. Todoric, J. Huber, R. Geyeregger, and T. Weichhart Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations Endocrinology 149 2008 1350 1357 (Pubitemid 351397930)
150. T. Nomiyama, D. Perez-Tilve, D. Ogawa, F. Gizard, Y. Zhao, and E.B. Heywood Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice J Clin Invest 117 2007 2877 2888 (Pubitemid 47529618)
151. R.M. Touyz Molecular and cellular mechanisms regulating vascular function and structureimplications in the pathogenesis of hypertension Can J Cardiol 16 2000 1137 1146
152. K. Rahmouni, M.L.G. Correia, W.G. Haynes, and A.L. Mark Obesity-associated hypertension: new insights into mechanisms Hypertension 45 2005 9 14 (Pubitemid 40066405)
153. S.S. Anand, Q. Yi, H.C. Gerstein, E. Lonn, R. Jacobs, and V. Vuksan Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease Circulation 108 2003 420 425 (Pubitemid 36935534)
154. Y. Aso Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis Front Biosci 12 2007 2957 2966
155. D.R. Faber, P.G. de Groot, and F.L. Visseren Role of adipose tissue in haemostasis, coagulation and fibrinolysis Obes Rev 10 2009 554 563
156. A.I. Vinik, T. Erbas, T.S. Park, R. Nolan, and G.L. Pittenger Platelet dysfunction in type 2 diabetes Diabetes Care 24 2001 1476 1485 (Pubitemid 33716440)
157. I. Mertens, and L.F. Van Gaal Obesity, haemostasis and the fibrinolytic system Obes Rev 3 2002 85 101 (Pubitemid 34827150)
158. Coca M, Cucuianu M, Hncu N. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen and von Willebrand factor. Rom J Intern Med 205;43:15-26.
159. M.C. Alessi, F. Peiretti, P. Morange, M. Henry, G. Nalbone, and I. Juhanvague Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease Diabetes 46 1997 860 867 (Pubitemid 27188265)
160. M. Cigolini, M. Tonoli, L. Borgato, L. Frigotto, F. Manzato, and S. Zeminian Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? Atherosclerosis 143 1999 81 90 (Pubitemid 29138705)
161. M.C. Alessi, D. Bastelica, P. Morange, B. Berthet, I. Leduc, and M. Verdier Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity Diabetes 49 2000 1374 1380 (Pubitemid 30624239)
162. I. Mertens, A. Verrijken, J.J. Michiels, M. Van der Planken, J.B. Ruige, and L.F. Van Gaal Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome Int J Obes (Lond) 30 2006 1308 1314 (Pubitemid 44141622)
163. A.M. Kanaya, F.C. Wassel, E. Vittinghoff, T.B. Harris, S.W. Park, and B.H. Goodpaster Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1 Arch Intern Med 166 2006 350 356 (Pubitemid 43244324)
164. E.D. Sprengers, and C. Kluft Plasminogen activator inhibitors Blood 69 1987 381 387 (Pubitemid 17022002)
165. C.Z. Song, T.E. Siok, and T.D. Gelehrter Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter J Biol Chem 273 1998 29287 29290 (Pubitemid 28509925)
166. N. Esemuede, T. Lee, D. Pierre-Paul, B.E. Sumpio, and V. Gahtan The role of thrombospondin-1 in human disease J Surg Res 122 2004 135 142 (Pubitemid 39441244)
167. C.H. Lundgren, S.L. Brown, T.K. Nordt, B.E. Sobel, and S. Fujii Elaboration of type-1 plasminogen activator inhibitor from adipocytes A potential pathogenetic link between obesity and cardiovascular disease Circulation 93 1996 106 110 (Pubitemid 26006576)
168. M.A. Mori, M. Liu, O. Bezy, K. Almind, H. Shapiro, and S. Kasif A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease Diabetes 59 2010 2960 2971
169. A.J. Kennedy, K.L.J. Ellacott, V.L. King, and A.H. Hasty Mouse models of the metabolic syndrome Dis Model. Mechan 3 2010 156 166